Allogene Therapeutics, Inc. ALLO-715 is the First Allogeneic anti-BCMA CAR T to Reveal Security, Efficacy and Sturdiness with Off-the-Shelf Comfort in A number of Myeloma SOUTH SAN FRANCISCO, Calif., Jan. 24, 2023 (GLOBE NEWSWIRE)...
Read More
5 Minutes